Inventor

SPADA ALFRED P

US55 patents

⚠️ This page may combine multiple inventors who share the name “SPADA ALFRED P”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

SPADA ALFRED P

RHONE POULENC RORER PHARMA

Bis mono- and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase

Protein tyrosine kinase aryl and heteroaryl quinazoline compounds having selective inhibition of HER-2 autophosphorylation properties

Aryl and heteroaryl quinazoline compounds which inhibit EGF and/or PDGF receptor tyrosine kinase

Bis mono-and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase

Bis mono- and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase

Compounds having antihypertensive, cardioprotective, anti-ischemic and antilipolytic properties

Bis mono- and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase

Styryl-substituted pyridyl compounds which inhibit EGF receptor tyrosine kinase

Compounds having antihypertensive, cardioprotective, anti-ischemic and antilipolytic properties

Aryl and heteroaryl quinazoline compounds which inhibit CSF-1R receptor tyrosine kinase

Compounds having antihypertensive and anti-ischemic properties

Bis mono- and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase

Bis mono- and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase

DI (1R)-(-)camphosulfonic acid) salt, preparation thereof and use thereof

Substituted (sulfinic acid, sulfonic acid, sulfonylamino or sulfinylamino) N-[(aminoiminomethyl)phenylalkyl]-azaheterocyclylamide compounds

Substituted sulfonic acid N-[(aminoiminomethyl)phenylalkyl]-azaheterocyclylamide compounds

Pyrazolo[3,4-g]quinoxaline compounds which inhibit PDGF receptor protein tyrosine kinase

Substituted sulfonic acid n- (aminoiminomethyl)phenylalkyl!-azaheterocyclamide compounds

Styryl-substituted monocyclic and bicyclic heteroaryl compounds which inhibit EGF receptor tyrosine kinase

Compounds having antihypertensive properties

Compounds having cardiotonic activity

Polyarylcarbamoylaza- and -carbamoylalkanedioic acids

Substituted (sulfinic acid, sulfonic acid, sulfonylamino or sulfinylamino) N- (aminominomethyl)phenylalkyl!-azaheterocyclylamide compounds

AVENTIS PHARMA INC

Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases

Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases

Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases

Aryl and heteroaryl quinazoline compounds which inhibit CSF-1R receptor tyrosine kinase

Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases

Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases

Compounds having antihypertensive, cardioprotective, anti-ischemic and antilipolytic properties

Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases

Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and /or p56lck tyrosine kinases

Substituted oxoazaheterocyclyl compounds

AVENTIS PHARM PROD INC

Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases

Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases

Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases

Bis mono-and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase

Substituted n-[(aminoiminomethyl or aminomethyl)phenyl]propyl amides

Substituted N-[(aminoiminomethyl or aminomethyl)phenyl]propyl amides

Substituted intermediate compounds for the preparation of n-[(aminoiminomethyl or aminomethyl)phenyl]propyl amides

RORER PHARMACEUTICAL CORP

Pyridooxazinone-pyridone compounds, cardiotonic compositions including the same, and their uses

Naphtheridinone- and pyridooxazinone-pyridone compounds, cardiotonic compositions including same, and their uses

Pyrido[2,3-d]pyrimidinone and imidazo[4,5-b]pyrimidinone

Pyridooxazinone-pyridazinone and pyrazolone compounds, cardiotonic compositions including the same, and their use

AVENTIS PHARMACETICAL PRODUCTS

Aryl and heteroaryl quinazoline compounds which inhibit CSF-1R receptor tyrosine kinase

AVENTIS PHARMA GMBH

Compounds having antihypertensive, cardioprotective anti-ischemic and antilipolytic properties

RHONE-POULENC INC

Styryl-substituted heteroaryl compounds which inhibit EGF receptor tyrosine kinase

RH & E CIR O & EE NE POULENC R

Method and composition for treating psoriasis with styryl-substituted pyridyl compounds

RHONE POULENC RORER INT

Styryl-substituted monocyclic and bicyclic heteroaryl compounds which inhibit EGF receptor tyrosine kinase

HISTOGEN INC

Caspase inhibitors and methods of use thereof